Lupin's recent FDA approval for the generic version of Diflucan, Fluconazole tablets, signifies a major achievement. This approval allows Lupin to manufacture and distribute varying dosages, potentially increasing accessibility of this crucial treatment for vaginal candidiasis. Manufactured in Lupin's Pithampur facility, this development could shift market dynamics.